Trump’s pharmaceutical tariffs will risk the lives of American patients

USA TODAY - For more and to sign up click here Marc L. Busch, opinion contributor On April 1, the Trump administration launched an investigation of whether imports of pharmaceuticals pose a national security risk. Given the relatively short period for public comments, it appears the answer is a foregone conclusion. Tariffs are expected by mid-May. These duties won’t just be economically wasteful: They’ll pummel…